Shelton Capital Management Viatris Inc Transaction History

Shelton Capital Management

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$11.27 - $13.53 $1.76 Million - $2.11 Million	155,808 New	155,808 $1.86 Million
Q4 2023 Feb 14, 2024	BUY	$8.77 - $10.85 $1,982 - $2,452	226 Added 0.07%	305,808 $3.31 Million
Q3 2023 Nov 14, 2023	BUY	$9.59 - $11.35 $2.93 Million - $3.47 Million	305,582 New	305,582 $3.01 Million
Q2 2023 Aug 10, 2023	BUY	$9.02 - $10.29 $2.75 Million - $3.14 Million	305,182 New	305,182 $3.05 Million
Q4 2021 Feb 11, 2022	SELL	$12.09 - $14.68 $196,462 - $238,550	-16,250 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$13.25 - $15.13 $1,311 - $1,497	-99 Reduced 0.61%	16,250 $220,000
Q2 2021 Aug 12, 2021	BUY	$12.97 - $16.15 $212,046 - $264,036	16,349 New	16,349 $234,000
Q1 2021 May 14, 2021	SELL	$13.59 - $18.54 $182,690 - $249,233	-13,443 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$14.3 - $18.74 $192,234 - $251,921	13,443 New	13,443 $252,000

1,102

933M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.2B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Shelton Capital Management, based on Form 13F filings with the SEC.

Stay updated on Shelton Capital Management with notifications on news.